Literature DB >> 12872930

Antioxidant properties of galantamine hydrobromide.

M Traykova1, T Traykov, V Hadjimitova, K Krikorian, N Bojadgieva.   

Abstract

The antioxidant properties of galantamine hydrobromide ((4alpha,6beta)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-ol hydrobromide) were studied in vitro, using luminol-dependent chemiluminescence and spectrophotometry. It was found that this compound was a scavenger of reactive oxygen species (ROS). By comparing the antioxidant effects of galantamine ((4alpha,6beta)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-ol), galantamine hydrobromide, narwedine (4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-one), and narwedine hydrobromide it was found that the antioxidant activity depended on the enolic OH group in the molecule. The presence of a quaternary nitrogen in the compound increased the strength of the scavenging effect. It is proposed that the antioxidant properties observed in vitro may contribute to the therapeutical effect of galantamine hydrobromide on patients with brain degeneration.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12872930     DOI: 10.1515/znc-2003-5-613

Source DB:  PubMed          Journal:  Z Naturforsch C J Biosci        ISSN: 0341-0382


  6 in total

1.  Subthreshold Concentrations of Melatonin and Galantamine Improves Pathological AD-Hallmarks in Hippocampal Organotypic Cultures.

Authors:  I Buendia; E Parada; E Navarro; R León; P Negredo; J Egea; M G López
Journal:  Mol Neurobiol       Date:  2015-06-17       Impact factor: 5.590

2.  Galantamine-Memantine Combination as an Antioxidant Treatment for Schizophrenia.

Authors:  Maju Mathew Koola; Samir Kumar Praharaj; Anilkumar Pillai
Journal:  Curr Behav Neurosci Rep       Date:  2019-05-17

Review 3.  Being right on Q: shaping eukaryotic evolution.

Authors:  Dave Speijer
Journal:  Biochem J       Date:  2016-11-15       Impact factor: 3.857

4.  Antidiabetic Effect of Galantamine: Novel Effect for a Known Centrally Acting Drug.

Authors:  Mennatallah A Ali; Hanan S El-Abhar; Maher A Kamel; Ahmed S Attia
Journal:  PLoS One       Date:  2015-08-11       Impact factor: 3.240

5.  Hypothesis: apo-lactoferrin-Galantamine Proteo-alkaloid Conjugate for Alzheimer's disease Intervention.

Authors:  Olufemi D Akilo; Pradeep Kumar; Yahya E Choonara; Priyamvada Pradeep; Lisa C du Toit; Viness Pillay
Journal:  J Cell Mol Med       Date:  2018-01-29       Impact factor: 5.310

Review 6.  Recent Progress on Biological Activity of Amaryllidaceae and Further Isoquinoline Alkaloids in Connection with Alzheimer's Disease.

Authors:  Lucie Cahlíková; Rudolf Vrabec; Filip Pidaný; Rozálie Peřinová; Negar Maafi; Abdullah Al Mamun; Aneta Ritomská; Viriyanata Wijaya; Gerald Blunden
Journal:  Molecules       Date:  2021-08-29       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.